RECRUITING

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.

Official Title

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Quick Facts

Study Start:2025-07-05
Study Completion:2026-09-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07048496

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 years or older;
  2. * completed intravesical treatment for non-muscle invasive bladder cancer within the past year Cohort 1 inclusion criteria for key stakeholders
  3. * Age 18 years or older;
  4. * experience with the delivery of BCG delivery for more than 2 years
  5. * Age 18 years or older;
  6. * diagnosed with non-muscle invasive bladder cancer and prescribed BCG for initial therapy
  1. * inability to provide informed consent
  2. * inability to undergo catheterization (i.e. - history of urethral stricture)
  3. * inability to receive BCG therapy (i.e. - previous reaction with BCG)
  4. * no access to mobile phone
  5. * inability to respond to written conversations in English

Contacts and Locations

Study Contact

Daniel Lee, PI, MD
CONTACT
215-615-3780
daniel.lee4@pennmedicine.upenn.edu

Study Locations (Sites)

Abramson Cancer Center
Philadelphia, Pennsylvania, 19104
United States

Collaborators and Investigators

Sponsor: University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-07-05
Study Completion Date2026-09-05

Study Record Updates

Study Start Date2025-07-05
Study Completion Date2026-09-05

Terms related to this study

Additional Relevant MeSH Terms

  • Bladder Cancer